Lisata Therapeutics Inc. (LSTA) — Capital Reinvestment Ratio

Latest as of June 2020: 0.00x

Lisata Therapeutics Inc. (LSTA) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow ($4.50 Million) in capital expenditures ($12.00K). See LSTA equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.50 Million
USD

Capital Expenditures

$12.00K
USD

Data as of

Jun 2020
Most recent filing

Lisata Therapeutics Inc. Capital Reinvestment Ratio (1992–2002)

This chart tracks Lisata Therapeutics Inc.'s Capital Reinvestment Ratio across 3 annual periods. Check Lisata Therapeutics Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Lisata Therapeutics Inc. (1992–2002)

Year-by-year Capital Reinvestment Ratio for Lisata Therapeutics Inc. from 1992 to 2002. For live market cap and broader valuation context, see market cap of Lisata Therapeutics Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2002 0.00x $1.01 Million $1.13K ▼ -99.9%
1993 1.06x $470.00K $500.00K ▲ +219.1%
1992 0.33x $240.00K $80.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow